ingest
cdrApp
2018-03-15T17:19:58.826Z
d591f2cd-3da7-4b31-9dd8-ee27dcb6a3ee
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-03-15T17:20:49.247Z
Setting exclusive relation
addDatastream
MD_TECHNICAL
fedoraAdmin
2018-03-15T17:21:00.638Z
Adding technical metadata derived by FITS
addDatastream
MD_FULL_TEXT
fedoraAdmin
2018-03-15T17:21:23.758Z
Adding full text metadata extracted by Apache Tika
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-03-15T17:21:46.516Z
Setting exclusive relation
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-05-16T19:22:24.899Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-10T20:09:36.290Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-17T16:25:55.164Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-02T16:24:25.153Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-08T15:52:08.662Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-14T20:12:12.067Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-16T16:01:32.222Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-09-21T13:37:06.232Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-09-26T16:31:02.635Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-10-10T16:50:29.522Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-10-11T17:23:32.741Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2019-02-28T00:24:58.221Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2019-03-19T19:42:17.332Z
Yael
Symes
Author
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
Winter 2017
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors; e-cigarettes; psychosocial factors; smoking beliefs; smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors, e-cigarettes, psychosocial factors, smoking beliefs, smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors; e-cigarettes; psychosocial factors; smoking beliefs; smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Health Behavior
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Yael
Symes
Creator
Department of Health Behavior
Gillings School of Global Public Health
SMOKING CESSATION IN CANCER SURVIVORS: EXPLORING PSYCHOSOCIAL WELLBEING, BELIEFS ABOUT SMOKING, AND E-CIGARETTE USE
Smoking after a cancer diagnosis is associated with various negative health outcomes and existing smoking cessation interventions for cancer survivors have not been effective in influencing cessation rates. The purpose of this dissertation is to better understand smoking-related factors uniquely influenced by receiving a cancer diagnosis that could be used to create more successful cessation interventions for cancer survivors.
Manuscript 1 used time-to-event analysis to assess whether psychosocial factors—distress, health-related quality of life (HRQOL), and perceived social support—at one year after diagnosis predicted whether survivors successfully quit smoking and the amount of time it took to quit in a longitudinal nationally representative sample of long-term cancer survivors from the American Cancer Society Study of Cancer Survivors (SCS-I; n = 341). Manuscript 2 assessed whether survivors of tobacco-related cancers reported higher perceived severity of health problems from smoking compared to survivors of non-tobacco-related cancers and explored whether this relationship was stronger for recently-diagnosed versus long-term survivors in a cross-sectional national sample from the Population Assessment of Tobacco Health—PATH—study (n = 433). Manuscript 3 identified e-cigarette use prevalence and reasons for use among cancer survivors who smoke (n = 433) and compared to smokers without a prior cancer diagnosis (n = 10,872) in the PATH study.
In Manuscript 1, survivors with low physical HRQOL were significantly less likely to quit smoking and took several more years to quit than survivors with high physical HRQOL. In Manuscript 2, survivors of tobacco-related cancer reported higher perceived severity of smoking than survivors of non-tobacco-related cancer and this relationship was the same for recently-diagnosed and for long-term survivors. In Manuscript 3, nearly 6 in 10 cancer survivors who smoke had used e-cigarettes, and nearly one quarter of survivors were currently doing so; rates were similar in those never diagnosed. The majority of both groups (>71%) reported using e-cigarettes for perceived health-related reasons—including smoking reduction.
Clinicians may want to assess physical HRQOL, perceived severity of smoking, and discuss the research on the efficacy of e-cigarettes as a quitting strategy with their patients who smoke to identify patients at particularly high risk of continued smoking and potential means for interventions.
2017-12
2017
Public health
cancer survivors; e-cigarettes; psychosocial factors; smoking beliefs; smoking cessation
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Shelley
Golden
Thesis advisor
Kurt
Ribisl
Thesis advisor
Marcella
Boynton
Thesis advisor
Deborah
Mayer
Thesis advisor
J.
Westmaas
Thesis advisor
text
Symes_unc_0153D_17432.pdf
uuid:476f4516-a9df-43d3-82ea-70dddbe49d6b
2019-12-31T00:00:00
2017-11-29T18:24:20Z
proquest
application/pdf
781784